• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于根治性切除胃癌患者复发风险评分的提议。

Proposal of a risk score for recurrence in patients with curatively resected gastric cancer.

作者信息

Ichikura T, Fujino K, Ikawa H, Tomimatsu S, Uefuji K, Tamakuma S

机构信息

First Department of Surgery, National Defense Medical College, Tokorozawa, Japan.

出版信息

Surg Today. 1993;23(9):759-64. doi: 10.1007/BF00311616.

DOI:10.1007/BF00311616
PMID:8219607
Abstract

In this study, 168 patients who underwent curative resection for gastric cancer with prognostic serosal invasion [ps(+)] and 150 without prognostic serosal invasion [ps(-)] were analyzed separately to determine the prognostic importance of clinicopathological factors, and identify which patients were at high risk of recurrence. A multivariate analysis of survival time using Cox's proportional hazard model revealed the important prognostic factors to be: Lymph node involvement, the classification of gross appearance, macroscopic serosal invasion, and interstitial connective tissue in the ps(+) group; and lymph node involvement, macroscopic serosal invasion, and venous invasion in the ps(-) group. We proposed a risk score of recurrence based on the results of a further multivariate analysis called Hayashi's Quantification Analysis II, in which recurrence was chosen as an objective variable and the above prognostic factors were chosen as explanatory variables. Eighty-four percent of the patients with a score of 0 or higher in the ps(+) group and 83% of those with a score of +6 or higher in the ps(-) group showed recurrence. Thus, we believe that this score is useful for identifying those patients at high risk of recurrence, who should receive intensive chemotherapy even after curative resection.

摘要

在本研究中,分别分析了168例接受胃癌根治性切除且伴有预后性浆膜侵犯[ps(+)]的患者和150例无预后性浆膜侵犯[ps(-)]的患者,以确定临床病理因素的预后重要性,并识别哪些患者具有高复发风险。使用Cox比例风险模型对生存时间进行多变量分析显示,ps(+)组的重要预后因素为:淋巴结受累、大体外观分类、肉眼浆膜侵犯和间质结缔组织;ps(-)组的重要预后因素为:淋巴结受累、肉眼浆膜侵犯和静脉侵犯。基于进一步的多变量分析(称为林氏量化分析II)结果,我们提出了复发风险评分,其中将复发作为目标变量,上述预后因素作为解释变量。ps(+)组中评分0或更高的患者有84%出现复发,ps(-)组中评分+6或更高的患者有83%出现复发。因此,我们认为该评分有助于识别那些具有高复发风险的患者,这些患者即使在根治性切除后也应接受强化化疗。

相似文献

1
Proposal of a risk score for recurrence in patients with curatively resected gastric cancer.关于根治性切除胃癌患者复发风险评分的提议。
Surg Today. 1993;23(9):759-64. doi: 10.1007/BF00311616.
2
Intraoperatively assessed macroscopic serosal changes in patients with curatively resected advanced gastric cancer: clinical implications for prognosis and peritoneal recurrence.根治性切除的进展期胃癌患者术中评估的宏观浆膜变化:对预后和腹膜复发的临床意义
Ann Surg Oncol. 2015 Sep;22(9):2940-7. doi: 10.1245/s10434-014-4352-8. Epub 2015 Jan 21.
3
The pattern and risk factors of recurrence of proximal gastric cancer after curative resection.根治性切除术后近端胃癌复发的模式和危险因素。
J Surg Oncol. 2013 Feb;107(2):130-5. doi: 10.1002/jso.23252. Epub 2012 Sep 4.
4
Prognostic impact of venous invasion in stage IB node-negative gastric cancer.IB 期淋巴结阴性胃癌中静脉侵犯的预后影响。
Gastric Cancer. 2015 Apr;18(2):297-305. doi: 10.1007/s10120-014-0362-2. Epub 2014 Apr 1.
5
Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence.早期胃癌复发——复发的淋巴结阴性早期胃癌患者淋巴结中微转移的存在情况
Hepatogastroenterology. 2007 Mar;54(74):620-4.
6
Prognostic factors of advanced gastric carcinoma without serosal invasion (pT2 gastric carcinoma).无浆膜侵犯的进展期胃癌(pT2期胃癌)的预后因素
Hepatogastroenterology. 1999 Jul-Aug;46(28):2669-72.
7
Extent of Serosal Changes Predicts Peritoneal Recurrence and Poor Prognosis After Curative Surgery for Gastric Cancer.浆膜变化程度可预测胃癌根治性切除术后的腹膜复发及不良预后。
Medicine (Baltimore). 2015 Oct;94(42):e1750. doi: 10.1097/MD.0000000000001750.
8
Prognostic factors in patients with advanced gastric cancer treated by noncurative resection: a multivariate analysis.非根治性切除治疗的晚期胃癌患者的预后因素:多变量分析
Hepatogastroenterology. 2001 Sep-Oct;48(41):1504-8.
9
Prognostic factors for survival in patients with hepatic recurrence after curative resection of gastric cancer.胃癌根治性切除术后肝转移患者生存的预后因素
World J Surg. 2009 Jul;33(7):1468-72. doi: 10.1007/s00268-009-0034-2.
10
Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.接受根治性胃切除术的胃癌患者中ADAM17表达的预后意义
Clin Transl Oncol. 2015 Aug;17(8):604-11. doi: 10.1007/s12094-015-1283-1. Epub 2015 Mar 19.

引用本文的文献

1
Proposal for a clinicopathological prognostic score for resected gastric cancer patients.胃癌患者切除术后的临床病理预后评分建议。
Saudi J Gastroenterol. 2021 Jan-Feb;27(1):44-53. doi: 10.4103/sjg.SJG_208_20.
2
Importance of positive peritoneal lavage cytology findings in the stage grouping of gastric cancer.阳性腹腔灌洗细胞学检查结果在胃癌分期分组中的重要性。
Surg Today. 1999;29(2):111-5. doi: 10.1007/BF02482234.

本文引用的文献

1
5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer.5-氟尿嘧啶、多柔比星和丝裂霉素(FAM)联合化疗用于晚期胃癌
Ann Intern Med. 1980 Oct;93(4):533-6. doi: 10.7326/0003-4819-93-4-533.
2
The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification.胃癌外科与病理学研究的一般规则。第一部分。临床分类。
Jpn J Surg. 1981 Mar;11(2):127-39. doi: 10.1007/BF02468883.
3
Human gastric carcinoma: prognosis in relation to macroscopic and microscopic features of the primary tumor.
人类胃癌:与原发性肿瘤宏观和微观特征相关的预后
J Natl Cancer Inst. 1983 Aug;71(2):275-9.
4
A multiple regression equation for prediction of posthepatectomy liver failure.一个用于预测肝切除术后肝衰竭的多元回归方程。
Ann Surg. 1984 Nov;200(5):658-63. doi: 10.1097/00000658-198411000-00018.
5
Histologic criteria of serosal rupture and prognosis in gastric carcinoma.
Cancer. 1972 Jan;29(1):180-90. doi: 10.1002/1097-0142(197201)29:1<180::aid-cncr2820290128>3.0.co;2-6.
6
A multifactorial approach for the prognosis of patients with carcinoma of the stomach after curative resection.一种用于胃癌根治性切除术后患者预后评估的多因素方法。
Surg Gynecol Obstet. 1986 Mar;162(3):229-34.
7
Evaluation of the prognostic factors in gastric cancer: the effect of chemotherapy on survival.
Br J Surg. 1987 Aug;74(8):715-20. doi: 10.1002/bjs.1800740822.
8
A phase II study of combined 5-fluorouracil, doxorubicin, and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomas.一项关于5-氟尿嘧啶、阿霉素和顺铂联合治疗晚期上消化道腺癌的II期研究。
J Clin Oncol. 1986 Jul;4(7):1053-7. doi: 10.1200/JCO.1986.4.7.1053.
9
[Clinico-pathological study on recurrent gastric cancer after curative resection].
Nihon Geka Gakkai Zasshi. 1988 Feb;89(2):173-80.
10
Prognostic factors in gastric cancer with serosal invasion. Univariate and multivariate analyses.伴有浆膜侵犯的胃癌的预后因素。单因素和多因素分析。
Arch Surg. 1989 Sep;124(9):1061-4. doi: 10.1001/archsurg.1989.01410090071015.